As shown in GEO databases, ER-negative (ER−), progesterone receptor-negative (PR−), and HER2-positive (HER2+) breast cancer patients had high QPRT expression (P < 0.0001) (Fig. 1D–F). This evidence concerns the gene ESR1 and breast cancer.